Podimetricscompanies that help diabetics prevent serious complications are working with HealthMed, a platform for employee health and wellness.
HealthMed aims to integrate Podimetrics’ SmartMat technology into a portfolio of benefits for large employers, hospitals and municipalities. The company also offers employee health and mental health programs.
Podimetrics’ SmartMat measures foot temperature in high-risk patients and scans for early signs of inflammation that can lead to wounds, amputations and diabetic foot ulcers.
“The partnership with HealthMed is a strong collaboration and we are excited to work together to support complex diabetic individuals at the highest risk of serious complications,” Dr. Jon Bloom, CEO of Podimetrics, said in a statement.
“We share a common mission to improve health outcomes with a focus on prevention. This collaboration aims to achieve that goal together.”
HealthMed founder Tracy Webster said that partnership with Podimetrics and innovative solutions for managing complex diabetes will benefit self-insured employers and improve the continuum of care.
“We look forward to the positive impact on health outcomes and overall cost of care,” Webster said in a statement.
Bigger trends
In March, Podimetrics partnered with Benefit Management Organization Alivi Health. This Alivi Health has incorporated SmartMat technology into its professional profit portfolio to enhance health plans and podiatrist benefits for payers.
In 2024, Podimetrics sued Ireland-based Bluedrop Medical for patent infringement. Blue Drop There are devices that allow diabetic people to scan their feet for potential instances of foot ulcers.
According to CompliantBlue Drop is said to “provide the sale and sale of means of infringing, committing and infringing the subsidiaries, employees, intermediaries, or product names directly and/or infringing.” [Podimetrics’] The case was dismissed after Podmetrics retracted its claim.
In 2022, Podimetrics scored $45 million in Series C Finance Round. Capital was used to expand the product development and research team at Podimetrics, increasing the number of services offered by the nurse support team.
Podimetrics rose in 2019 Series B funding amounted to $13.4 million. Rock Health, Norwich Ventures and Scientific Health Development took part in the round.
Other companies in the diabetes field include Dexcom, which made a $75 million strategic investment in health tracking ring maker Oura in 2024, has established a strategic partnership that enables two-way data flow between Dexcom’s continuous glucose monitor (CGM) and Oura Ring. Dexcom’s $75 million investment has brought Urosia to a valuation of over $5 billion.
Diabetes and Insulin Management Software Company Glytec and pharmaceutical company Roche joined forces last year to allow Glytec software to be used in connection with Roche’s Point of Care Smart Device Hospital’s Glycine System Covas System and global markets.
According to Roche, Cobas Pulse’s strip architecture provides lab-like results, reducing the need to repeat testing. This system can be used in all patient populations, including neonates and intensive care patients.
